GLYCOPYRROLATE MSDS PDF

SAFETY DATA SHEET. PRODUCT: Glycopyrrolate Injection USP. Section 1: PRODUCT AND COMPANY INFORMATION. 54/1, Boodhihal village,. Nelamangala. Glycopyrrolate. 1-Methylpyrrolidyl alpha-phenylcyclopentaneglycolate methobromide;. Glycopyrrolate bromide; Glycopyrronium bromide. Glycopyrronium (as the bromide salt glycopyrrolate) is a synthetic anticholinergic agent In October , glycopyrrolate was approved by the FDA for use as a FDA label. Download ( KB). MSDS. Download ( KB).

Author: Zurn Malajind
Country: Zambia
Language: English (Spanish)
Genre: Education
Published (Last): 3 December 2006
Pages: 486
PDF File Size: 18.2 Mb
ePub File Size: 16.84 Mb
ISBN: 658-1-36686-887-6
Downloads: 78427
Price: Free* [*Free Regsitration Required]
Uploader: Gardaramar

Bucindolol Glycopygrolate risk or severity of Tachycardia can be increased when Glycopyrronium is combined jsds Bucindolol. The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Nabiximols. The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Potassium Chloride. The therapeutic efficacy of Docusate can be decreased when used in combination with Glycopyrronium.

Paromomycin The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Paromomycin. Benzquinamide The risk or severity of adverse effects can be increased when Benzquinamide is combined with Glycopyrronium.

Tubocurarine The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Tubocurarine. The risk or severity of adverse effects can be increased when Pipecuronium glycoopyrrolate combined with Glycopyrronium.

Glycopyrronium

The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Glycopyrronium. Loratadine Glycopyrronium may increase the anticholinergic activities of Loratadine. The therapeutic efficacy of Plantago seed can be decreased when used in combination with Glycopyrronium. The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Glycopyrronium.

Phentermine The risk or severity of Tachycardia can be increased flycopyrrolate Phentermine is combined with Glycopyrronium.

Cyclopentolate The risk or glycoyrrolate of adverse effects can be increased when Cyclopentolate is combined with Glycopyrronium. The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Bekanamycin.

TOP Related  A HISTORY OF MAGIC BY BATHILDA BAGSHOT PDF

Thiotepa The therapeutic efficacy of Glycopyrronium can be decreased when glycopyrrllate in combination with Thiotepa. Ritobegron The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Ritobegron. Butabarbital Butabarbital may increase the anticholinergic activities of Glycopyrronium.

Bethanidine The risk or severity of Tachycardia can be increased when Bethanidine is combined with Glycopyrronium.

The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Ergonovine. The risk glcyopyrrolate severity of adverse effects can be increased when Glycopyrronium is combined with Nicomorphine.

Glycopyrronium – DrugBank

Etybenzatropine The risk or severity of adverse effects can be increased when Etybenzatropine is combined with Glycopyrronium. The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Glycopyrronium. Aripiprazole The risk or severity of adverse effects can be increased when Aripiprazole is combined with Glycopyrronium.

Glycopyrronium may increase the gastrointestinal motility reducing activities of Glucagon recombinant. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Amibegron. The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Glycopyrronium. The therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Glycopyrronium. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Lisdexamfetamine.

Poldine The risk or severity of adverse effects can be increased when Poldine is combined with Glycopyrronium. Biperiden The risk or severity of adverse effects can be increased when Biperiden is combined with Glycopyrronium.

The glycopytrolate or severity of adverse effects can be increased when Glycopyrronium is combined with Aclidinium. Cinchocaine The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Cinchocaine.

Quinethazone The serum concentration of Quinethazone can be increased when it is combined with Glycopyrronium. Amitraz The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Amitraz. The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Carfentanil.

TOP Related  CAMUS MYTHOS DES SISYPHOS PDF

The therapeutic efficacy vlycopyrrolate Magnesium can be decreased when used in combination with Glycopyrronium. The risk or severity of Tachycardia mmsds be increased when Glycopyrronium is combined with Nebivolol. Glycopyrronium Targets 3 Biointeractions 3. Dopexamine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Dopexamine. The risk or severity of Tachycardia can be increased when Atomoxetine is combined with Glycopyrronium.

The risk or severity of adverse effects can be increased when Aripiprazole is combined with Glycopyrronium. The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Metrifonate.

Venlafaxine The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Glycopyrronium. Phenmetrazine The risk or severity of Tachycardia can be increased when Phenmetrazine is combined with Glycopyrronium. Side effects include dry mouth, difficult urinating, heachaches, diarrhea and constipation. Ramipril The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Ramipril.

Phenazocine The glyycopyrrolate or severity of adverse effects can be increased when Glycopyrronium is combined with Phenazocine. Surinabant The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Surinabant.

Detomidine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Detomidine. The serum concentration of Polythiazide can be blycopyrrolate when it is glycopyrorlate with Glycopyrronium. Magnesium cation The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Glycopyrronium. Methadone Methadone may increase the glycoopyrrolate activities of Glycopyrronium.